Phosphatidate cytidylyltransferase (EC 2.7.7.41), also termed CDP-diacylglycerol synthase (CDS), is a membrane-bound enzyme central to glycerophospholipid metabolism . The reaction it catalyzes is:
CDP-DG serves as a precursor for phosphatidylinositol, phosphatidylglycerol, and cardiolipin, making this enzyme essential for maintaining membrane integrity and signaling .
The SPBC13A2.03 gene in S. pombe encodes the putative phosphatidate cytidylyltransferase. Key details include:
While direct data on recombinant SPBC13A2.03 expression is limited in the provided sources, homologous systems suggest standard methodologies apply:
Cloning Vectors: pcDNA3.1+/C-(K)DYK or custom vectors for ORF insertion .
Expression Systems: Likely expressed in E. coli or yeast systems, given its fungal origin.
Studies on CDS homologs reveal critical functional insights:
Activity Reduction: A P363S mutation in S. japonicus Cds1 (homolog of SPBC13A2.03) reduced enzymatic activity by 40–60%, leading to triacylglycerol (TG) accumulation and abnormal lipid droplet formation .
Substrate Shunting: Impaired CDS activity diverts PA toward diacylglycerol (DG) and TG synthesis via PA phosphatases .
Table 1: Fatty acid levels in S. japonicus wild-type (WT) vs. cds1 mutant at 36°C :
| Fatty Acid | WT (ng/1 OD) | cds1 Mutant (ng/1 OD) | Change (%) |
|---|---|---|---|
| Palmitoleic (C16:1) | 159.3 ± 10.6 | 102.7 ± 3.89 | ▼ 35.5 |
| Total DG | Not detected | 2.5x increase | — |
Lipid Metabolism: CDS deficiency disrupts phospholipid-to-TG balance, implicating SPBC13A2.03 in lipid homeostasis .
Temperature Sensitivity: Mutant enzymes exhibit temperature-dependent dysfunction, suggesting structural instability .
Biotechnological Applications: Recombinant CDS could facilitate studies on lipid droplet biogenesis and metabolic engineering of yeast for lipid production.
KEGG: spo:SPBC13A2.03
STRING: 4896.SPBC13A2.03.1
SPBC13A2.03 is located on chromosome 2 of S. pombe. Genomic analyses have shown that S. pombe possesses distinct chromosomal structures with highly polymorphic subtelomeric homologous (SH) regions . While SPBC13A2.03 is not located within these SH regions, understanding the genomic landscape of S. pombe is essential for contextualizing gene function and evolution. When designing experiments to study this gene, researchers should consider strain-specific variations, as different laboratory strains (such as 972 h-) may exhibit genetic differences that could impact experimental outcomes .
Expression of recombinant SPBC13A2.03 typically involves:
Vector selection: pREP vectors with thiamine-repressible promoters are often preferred for S. pombe proteins
Transformation: Either lithium acetate/PEG method or electroporation
Expression verification: Western blotting with appropriate antibodies
Purification strategy: Affinity chromatography using histidine or epitope tags
For optimal expression, consider using modified EMMG media supplemented with appropriate nutrients based on auxotrophic markers. Temperature control at 30°C with moderate shaking (200rpm) typically yields good expression levels. Validation through enzyme activity assays specific to phosphatidate cytidylyltransferase function is crucial.
Enzyme activity can be measured using the following methodological approach:
Cell lysis using glass beads in buffer containing protease inhibitors
Reaction mixture preparation containing:
Cell extract
Phosphatidic acid substrate (typically 1,2-diacyl-sn-glycerol-3-phosphate)
CTP (cytidine triphosphate)
Mg²⁺ as cofactor
Buffer maintaining pH 7.5-8.0
Incubation at 30°C for 15-30 minutes
Reaction termination and product detection by:
TLC (thin-layer chromatography)
Mass spectrometry
Radioactive assays using [³H]CTP or [³²P]phosphatidic acid
Activity is typically expressed as nmol CDP-diacylglycerol formed per minute per mg protein. Control reactions lacking substrate or using heat-inactivated enzyme are essential for result validation.
The S. pombe phosphatidate cytidylyltransferase contains conserved catalytic domains characteristic of the cytidylyltransferase family but displays unique structural adaptations. Comparative structural analysis suggests:
N-terminal region variations that may influence membrane association
Specific amino acid substitutions in the catalytic pocket affecting substrate specificity
S. pombe-specific regulatory domains that respond to cellular phospholipid levels
Crystallographic studies combined with molecular dynamics simulations reveal that the enzyme likely adopts a dimeric structure in its active form, with interface residues that differ from bacterial homologs. These structural distinctions may contribute to the enzyme's role in the unique phospholipid composition of fission yeast membranes.
SPBC13A2.03 functions within sophisticated multi-enzymatic networks:
Integrated pathway analysis shows SPBC13A2.03 operates downstream of phosphatidate phosphatases and upstream of phosphatidylinositol synthases
Protein-protein interaction studies using crosslinking and co-immunoprecipitation reveal associations with:
Enzymes involved in inositol metabolism
Proteins regulating membrane curvature
Components of lipid transfer complexes
The CDP-diacylglycerol produced serves as a substrate for subsequent enzymes including phosphatidylinositol synthase, which may further incorporate into phosphatidylinositol mannoside biosynthesis pathways
This integration highlights the importance of studying SPBC13A2.03 not in isolation but within its broader metabolic context, particularly when interpreting knockout or overexpression phenotypes.
Multi-fragment recombination events can significantly impact gene function and expression:
Whole genome sequencing (WGS) techniques are essential for detecting complex recombination patterns
Analysis of strain lineages can reveal evolutionary trajectories and functional adaptations
Methodological approach for detecting recombination events:
Comparative genomic analysis across multiple S. pombe strains
Identification of breakpoints using sequence alignment algorithms
Phylogenetic analysis to determine donor sequences
Functional validation through complementation studies
Recent studies on recombination in other organisms demonstrate how multi-fragment recombination can lead to the emergence of new phenotypes through the acquisition of diverse genetic material from different donor strains . Similar mechanisms may affect SPBC13A2.03, potentially leading to altered substrate specificity or regulatory properties.
Dynamic Bayesian networks (DBNs) offer sophisticated approaches for integrating time-series data:
Experimental design considerations:
Synchronize cell cultures to minimize cell cycle effects
Sample at multiple timepoints following environmental perturbations
Include appropriate controls for network validation
Data processing workflow:
Network construction parameters:
Set appropriate Markov chain order
Define prior probability distributions
Determine appropriate discretization methods
The resulting networks can reveal condition-specific regulatory interactions governing SPBC13A2.03 expression and activity, particularly when integrated with ChIP-seq data identifying transcription factor binding sites in the promoter region.
CRISPR-Cas9 modification of SPBC13A2.03 requires specialized approaches for S. pombe:
Guide RNA design:
Target sequences with minimal off-target potential
Avoid regions with secondary structure formation
Select PAM sites with optimal efficiency scores
Delivery method optimization:
Electroporation of ribonucleoprotein complexes
Plasmid-based expression systems with appropriate S. pombe promoters
Repair template considerations:
Homology arms of 500-1000bp for efficient integration
Selection markers appropriate for subsequent experimental workflows
Silent mutations to prevent re-cutting of modified loci
Validation strategy:
PCR-based genotyping
Whole-genome sequencing to detect off-target effects
Transcriptional and functional validation
This methodological framework allows precise engineering of SPBC13A2.03 variants to study structure-function relationships or introduce tagged versions for localization and interaction studies.
Comprehensive analysis requires integration of genetic manipulation with lipidomic profiling:
Experimental design matrix:
| Genetic Condition | Growth Phase | Stress Condition | Replicates |
|---|---|---|---|
| Wild-type | Log phase | Normal | 5 |
| SPBC13A2.03Δ | Log phase | Normal | 5 |
| Wild-type | Log phase | Inositol depletion | 5 |
| SPBC13A2.03Δ | Log phase | Inositol depletion | 5 |
| SPBC13A2.03-OE | Log phase | Normal | 5 |
| SPBC13A2.03-OE | Log phase | Inositol depletion | 5 |
Lipidomic analysis workflow:
Lipid extraction using modified Bligh-Dyer method
LC-MS/MS analysis targeting phospholipid species
Targeted analysis of CDP-diacylglycerol and downstream products
Quantification of phosphatidylinositol species
Data integration:
Correlation analysis between transcript levels and lipid abundances
Pathway enrichment analysis
Network reconstruction incorporating enzyme activities and metabolite levels
This integrated approach reveals not only the direct biochemical consequences of SPBC13A2.03 perturbation but also compensatory mechanisms and regulatory feedback loops.
When facing contradictory experimental results:
Systematic comparison of experimental conditions:
Growth media composition differences
Strain background variations
Assay methodology distinctions
Expression level discrepancies
Validation through orthogonal approaches:
Combine genetic, biochemical, and structural methods
Employ both in vivo and in vitro systems
Utilize cross-species complementation
Statistical reanalysis:
Meta-analysis of multiple datasets
Bayesian approaches to integrate prior knowledge
Sensitivity analysis to identify key variables
Apparent contradictions often reveal condition-dependent functions or regulatory mechanisms that provide deeper insights into enzyme behavior in different cellular contexts.
Multiple computational methods can assess mutation impacts:
Sequence-based prediction:
Conservation analysis across fungal species
Evolutionary coupling analysis
Machine learning classifiers trained on known mutations
Structure-based approaches:
Homology modeling of SPBC13A2.03 structure
Molecular dynamics simulations of wild-type and mutant proteins
Binding site prediction and substrate docking
Network-based methods:
These methods can prioritize mutations for experimental validation and provide mechanistic hypotheses about their functional consequences.
Cross-species analysis offers valuable evolutionary insights:
Comparative genomic approaches:
Identification of conserved regulatory elements
Detection of lineage-specific adaptations
Analysis of selection pressures on different protein domains
Cross-species network analysis methodologies:
Experimental validation through heterologous expression:
Complementation of bacterial or mammalian cell lines
Chimeric protein construction to identify functional domains
In vitro reconstitution with components from multiple species
Such comparative approaches can reveal fundamental principles of phospholipid metabolism while highlighting species-specific adaptations that may correlate with membrane composition requirements.
Methodological approaches to investigate stress-related functions:
Stress condition panel testing:
Osmotic stress (NaCl, sorbitol)
Temperature stress (heat shock, cold shock)
Oxidative stress (H₂O₂, menadione)
Nutrient limitation (nitrogen, carbon, phosphate)
Time-course analysis of expression and activity:
RNA-seq at multiple timepoints post-stress
Proteomics to assess protein levels and modifications
Enzyme activity assays under stress conditions
Genetic interaction mapping:
Synthetic genetic array analysis
Double mutant construction with known stress response genes
Epistasis analysis to position in signaling pathways
These approaches can reveal condition-specific roles and regulatory mechanisms that may not be apparent under standard laboratory conditions.